One of the treatment options of advanced ovarian cancer is the combination of cyclophosfamide and cisplatinum or carboplatinum. Platinum compounds and alkylating agents are rarely responsible for hepatic toxicity. We report a case of a rare manifestation of hepatotoxicity in a patient treated with carboplatinum administered at standard doses.

Carboplatin-Related Hepatotoxicity

F. STIVALA;
2003

Abstract

One of the treatment options of advanced ovarian cancer is the combination of cyclophosfamide and cisplatinum or carboplatinum. Platinum compounds and alkylating agents are rarely responsible for hepatic toxicity. We report a case of a rare manifestation of hepatotoxicity in a patient treated with carboplatinum administered at standard doses.
Carboplatinum; Hepatotoxicity; Ovarian cancer
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/22905
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact